Dry Eye Disease Market Size - By Product (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements), By Disease Type (Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome), By Distribution Channel, & Forecast, 2023 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationDry Eye Disease Market Size - By Product (Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Oral Omega Supplements), By Disease Type (Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome), By Distribution Channel, & Forecast, 2023 – 2032
Dry Eye Disease Market Size
Dry eye disease market size was valued at over USD 6 billion in 2022 and is projected to reach around USD 12.3 billion by 2032. This incremental growth rate is owing to increasing prevalence of dry eye disease and associated ailments coupled with technological advancements in the products used for the treatment of these disorders.
Incrementally ageing population have augmented the demand for dry eye disease treatment devices thereby increasing awareness among several people across the globe. Geriatric population base are more susceptible to ophthalmic ailments as eye discomfort, redness, blurred vision, and dryness are some of the major symptoms observed among ageing population. Technological advancements in therapeutic and diagnostic products and ongoing research and development activities to develop innovative treatments by industry players is anticipated to drive the market growth. Factors such as healthcare spending, patient demographics, and technological advancements exert a significant influence on the market.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Dry Eye Disease Market Size in 2022 | USD 6 billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 7.4% |
| 2032 Value Projection | USD 12.3 billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 190 |
| Tables, Charts & Figures | 351 |
| Segments covered | Product, Disease Type, Distribution Channel, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Rising awareness regarding dry eye conditions and improved access to healthcare services have led to a surge in the demand for dry eye treatment devices. With the expanding market, there is a growing focus on developing personalized and targeted treatments, along with improved diagnostics and management approaches. Continued research and innovation are expected to enhance the understanding and treatment of dry eye disease, ultimately improving the quality of life for individuals affected by this condition thereby driving the market growth.
Dry eye disease (DED), also known as dry eye syndrome, is a common ocular condition characterized by insufficient tear production. This disease is specified by insufficient tear poor tear quality, leading to symptoms such as eye discomfort, redness, blurred vision, and dryness.
The cost of treating dry eye can be a major burden for many. Essential medications and devices can leave a big financial dent, making it challenging to stay on track with the treatment plan. For example, punctal plugs, which are small devices inserted into the tear ducts, can cost between $500 and $950. Eye drops, like cyclosporine, which helps reduce inflammation, can be equally expensive, with a single 30-day supply costing around $300. These expenses can make it difficult for people to access the care they need for their dry eye symptoms. And as a result, it could hinder the growth of the dry eye treatment market in the future.
Moreover, the high cost of treatment drugs and products can also impact healthcare systems and insurance providers, leading to reimbursement challenges and financial burdens. This may result in limited coverage or restrictions on access to certain medications or therapies, further hindering market growth. The high cost of dry eye disease treatment drugs and products presents a potential impediment, ongoing efforts to improve affordability and access could help overcome these challenges and foster market progress.
COVID-19 Impact
The recent outbreak of COVID-19 had negatively influenced the dry eye disease market revenue, specifically during the initial phase of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during the pandemic phase. These conditions severely impacted the market growth. Several hospitals and healthcare facilities globally experienced a significant decline in patient visits for diagnosis and treatment of dry eye disorders and other related chronic conditions.
The COVID-19 pandemic has reduced visits to healthcare facilities, causing medical services in several countries to be delayed, including ophthalmic procedures. During the pandemic, many individuals postponed or avoided non-urgent healthcare visits, including eye care appointments. This led to delayed diagnosis and treatment of dry eye disease, resulting in missed opportunities for intervention and management.
Dry Eye Disease Market Trends
Increasing prevalence of eye-related diseases is anticipated to drive the market share. The global population is experiencing a significant increase in the aging demographic. With age, the risk of developing eye-related diseases, including dry eye disease, increases significantly. The prevalence of dry eye disease tends to be higher in older individuals. For instance, according to an article published by the Karger Journal, in 2022 the prevalence rate of dry eye disease among people aged above 50 years in Asia was estimated to be around 50% and is expected in increase in the coming years.
This high prevalence rate is set to augment the demand for dry eye disease treatment products globally. Prolonged screen time and decreased blink rate associated with digital device use can contribute to dry eye symptoms. The increasing dependence on digital devices has resulted in a higher prevalence of dry eye disease among all age groups.
Dry eye disease often coexists with other systemic conditions, such as autoimmune diseases, diabetes, and thyroid disorders. The rising prevalence of these comorbidities contributes to the increasing prevalence of dry eye disease. There has been a growing awareness and understanding of dry eye disease among both healthcare professionals and the general population. Increased knowledge about the condition has led to improved diagnosis rates. Eye care professionals are better equipped to identify and diagnose dry eye disease, leading to a higher reported prevalence.
Dry Eye Disease Market Analysis
Dry eye disease is a common problem, and luckily there are many treatment options available. These includeEye drops like cyclosporine or corticosteroids to reduce inflammation Artificial tears to lubricate the eyes Punctal plugs to keep tears from draining away Oral omega supplements to improve tear quality Other treatments, like prescription eye drops or surgery One of the most popular options is cyclosporine, which can effectively treat dry eye disease. Inflammation on the eye's surface often causes this condition. Cyclosporine is an anti-inflammatory medication that works by calming the cells that trigger inflammation. This reduces inflammation and improves the eye's health. Cyclosporine also stabilizes the tear film. It does this by boosting tear production from the eye's glands. This helps lubricate the eye's surface, reducing dry eye symptoms.
Cyclosporine has been shown to provide significant symptom relief in patients with dry eye disease. It helps to reduce the discomfort, dryness, grittiness, and foreign body sensation commonly experienced by individuals with this condition. By addressing the underlying inflammation and promoting tear production, cyclosporine can improve the overall quality of life for patients. Cyclosporine is often used as a long-term management option for chronic dry eye disease.
Have you ever felt like your eyes were parched and scratchy, like a desert in the middle of your face? That could be dry eye disease. There are two main types of dry eye disease1. The Oil Shortage This happens when your eyes don't make enough of the oily part of your tears. Think of your tears as a pizzathe watery part is the cheese and sauce, while the oily part is the crispy crust that keeps everything yummy and moist. Without enough oily crust, the watery part evaporates too quickly, leaving your eyes feeling like a dried-up pizza. This oil shortage can be caused by problems with the oil glands in your eyelids or by allergies and skin conditions like rosacea. 2. The Water Crisis This is when your eyes just don't produce enough tears in the first place. It's like a faucet that's turned off. Certain eye infections or medications can cause this, or it can be a sign of other health problems like diabetes or rheumatoid arthritis. Dry eye disease affects a lot of people. In 2022, it was estimated that over 1 billion people worldwide had problems with their oil glands. And as more and more people face these dry eye woes, the demand for treatments is only expected to grow.
Modern lifestyles, characterized by increased digital device use, prolonged screen time, and reduced blink rate, contribute to the development of evaporative dry eye syndrome. As these lifestyle factors continue to be prevalent, the incidence of evaporative dry eye syndrome is expected to rise. Evaporative dry eye syndrome becomes more common with age, primarily due to the age-related changes in the meibomian glands and the eyelid structure. As the global population continues to age, the prevalence of evaporative dry eye syndrome is projected to increase.
How to Find Relief for Dry Eyes If you're struggling with dry eyes, here's what you can doHospital Pharmacy- Head here if you have severe dry eyes. They offer a broader range of treatments and expert advice from pharmacists. Regular Pharmacy - Visit your local pharmacy for over-the-counter eye drops that can soothe mild to moderate dry eyes. It's a convenient option, but they may not have the same depth of knowledge as hospital pharmacies. Online Pharmacy - Order eye drops online, but make sure to check the reputation of the source. Some online pharmacies sell questionable products. Remember, it's always wise to consult an eye doctor for a proper diagnosis and treatment plan. They can guide you based on your specific needs.
Hospital pharmacies are often conveniently located within healthcare facilities, providing easy access for patients seeking dry eye disease treatment. Additionally, availability of highly skilled healthcare professionals coupled with robust healthcare infrastructure and appropriate patient assistance for a comprehensive range of treatment options underscores the importance of hospital pharmacies thereby augmenting the market trends.
Dry eye is a serious issue affecting countless individuals in North America. The market for its treatment reached an impressive $2.4 billion in 2022, driven by several key factors. One major contributor is the presence of dominant players within the industry. These large corporations invest heavily in research and development, offering innovative treatment options. Another driving factor is the rising prevalence of dry eye disease. Factors such as aging, increased use of digital devices, and environmental exposures have led to a significant surge in the number of people suffering from dry eye. In the United States alone, the American Academy of Ophthalmology estimates that around 20 million people have dry eye. This figure is projected to increase in the coming years. As a result of this growing need for treatment, the market for dry eye disease remedies is poised for further expansion. There is a high demand for anti-inflammatory medications used to diagnose and treat dry eye in the region, contributing to the market's sustained growth.
Dry Eye Disease Market Share
Some of the major players operating in the dry eye disease market are
- AbbVie, Inc
- AFT Pharmaceuticals
- Alcon
- Bausch & Lomb
- Johnson & Johnson Services, Inc
- Novartis AG
- OASIS Medical
- Otsuka Pharmaceutical Co., Ltd
- Oyster Point Pharma Inc
- Santen Pharmaceutical Co., Ltd
- Sentiss Pharma Pvt. Ltd
- Sun Pharmaceutical Industries Ltd
- Thea Pharmaceuticals Ltd
- VISUfarma
- Takeda Pharmaceutical Company Ltd
These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
Dry Eye Disease Industry Leaders
- In January 2022, Alcon announced the launch of Systane, a complete preservative-free lubricant eye drop in the Europe. This eye drop is intended for the treatment of dry eye disease and provides dry eye relief by hydrating and protecting all layers of the tear film. This innovative launch heled the company to enhance their geographic presence and increase the customer base.
- In October 2020, Kala Pharmaceuticals, Inc., announced that they had received the U.S. FDA approval for their EYSUVIS an ophthalmic suspension. EYSUVIS, a loteprednol etabonate ophthalmic suspension 0.25% is used for the short-term treatment of the signs and symptoms of dry eye disease. This regulatory approval helped the company to enhance their R&D capabilities and increase their product portfolio.
Dry Eye Disease market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Product, 2018 - 2032 (USD Million)
- Cyclosporine
- Topical Corticosteroids
- Artificial Tears
- Punctal Plugs
- Removable
- Dissolvable
- Oral Omega Supplements
- Others
By Disease Type, 2018 - 2032 (USD Million)
- Evaporative Dry Eye Syndrome
- Aqueous Deficient Dry Eye Syndrome
By Distribution Channel, 2018 - 2032 (USD Million)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Philippines
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Egypt
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy